| Carol M. Moore |
Carol M. Moore is currently working as the Senior VP-Regulatory Affairs, Quality & Clinical at Cerus Corp. She started this position in 2013. Prior to her current role, she worked as the Vice President-Worldwide Regulatory Affairs at Bayer Corp. Ms. Moore holds an MBA from New York University and an undergraduate degree from The Cooper Union School of Engineering. |
| Vivek K. Jayaraman |
Vivek K. Jayaraman is currently the Chief Operating Officer at Cerus Corp. He previously worked as the Vice President-Global Marketing at Medtronic, Inc. and as the Vice President-Global Sales & Marketing at TriVascular, Inc. From 2014 to 2016, he served as the Head-Media Relations and VP-Global Sales & Marketing at Trivascular Technologies, Inc. He also held the position of Vice President-Commercial Operations at Trivascular2, Inc. from 2009 to 2011. Mr. Jayaraman completed his undergraduate degree at the University of Michigan and obtained an MBA from The Wharton School of the University of Pennsylvania. |
| Suzanne Margerum |
Suzanne Margerum is currently the Vice President-Development & Manufacturing at Cerus Corp. She previously worked as the Senior Corporate Counsel at Zynga, Inc. from 2000 to 2011. She received her undergraduate degree from The University of Chicago and the University of Colorado Boulder. |
| Daniel N. Swisher |
Daniel N. Swisher's current job(s) include Chairman at Cerus Corp., Independent Director at Corcept Therapeutics, Inc., and Director at Protagonist Therapeutics, Inc. Mr. Swisher's former job(s) include President, CEO, Secretary & Director at Sunesis Pharmaceuticals, Inc., Senior Vice President-Sales & Marketing at ALZA Corp., President & Chief Operating Officer at Jazz Pharmaceuticals, Inc., and President at Jazz Pharmaceuticals Plc. Mr. Swisher's education history includes an undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business. |
| Chrystal N. Menard |
Chrystal N. Menard is currently the Chief Legal Officer & General Counsel at Cerus Corp. Prior to her current position, she worked as a Partner at Cooley LLP from 2000 to 2011. She also worked as a Senior Corporate Counsel at Zynga, Inc. Ms. Menard received a graduate degree from The University of Chicago and an undergraduate degree from The University of Colorado. |
| Alicia Goodman |
Alicia Goodman is currently the Chief Human Resources Officer at Cerus Corp. Prior to this, she was the Senior Vice President of Human Resources at Aimmune Therapeutics, Inc. from 2019 to 2023. She also served as the Vice President of Human Resources at Novartis AG and the Senior VP, Chief People & Culture Officer at Berg LLC. Ms. Goodman received her undergraduate degree from Michigan State University and her graduate degree from Central Michigan University. |
| Laurence M. Corash |
Laurence M. Corash is the founder of Cerus Corp., a company founded in 1991, where he holds the title of Chief Scientific Officer. He is currently working at The University of California, San Francisco as a Professor since 1982. |
| Richard J. Benjamin |
Richard J. Benjamin is currently the Director & Director-North America Region at the International Society Blood Transfusion, Chief Medical Officer at Cerus Corp., and a Member of the American Association of Blood Banks. Previously, he was the Director at Point Therapeutics, Inc. from 2004 to 2008, Director at DARA BioSciences, Inc. in 2008, Medical Director-Adult Transfusion Service at Harvard University, and Chief Medical Officer at American Red Cross, Inc. He holds a doctorate degree from the University of Cambridge. |
| Kevin Dennis Green |
Kevin Dennis Green is currently the Chief Financial Officer & Vice President-Finance at Cerus Corp. He previously worked as the Finance Director & Assistant Controller at Macromedia, Inc. from 2000 to 2006. Before that, he was a Member at PricewaterhouseCoopers LLP. Mr. Green obtained his undergraduate degree from California State University-Fresno. |
| William Mariner Greenman |
William Mariner Greenman is currently the President, Chief Executive Officer & Director at Cerus Corp. He previously served as an Independent Director at Aduro BioTech, Inc. and Chinook Therapeutics, Inc. He also held the position of Senior Vice President-Biotech Division at Baxter International, Inc. Mr. Greenman obtained his undergraduate degree from Stanford University. |
| Ann Lucena |
Ann Lucena is currently the Chief Executive Officer at San Ramon Regional Medical Center LLC and an Independent Director at Cerus Corp. She is also a Director at HBS Alumni Angels Association. Previously, she worked as the President-Hospital Operations at Tenet Healthcare Corp. Ms. Lucena received her undergraduate degree from Stanford University and her MBA from Harvard Business School. |
| Jami K. Dover Nachtsheim |
Ms. Jami K. Nachtsheim is an Independent Director at Telesis Bio, Inc., an Independent Director at Cerus Corp. and an Independent Director at Intuitive Surgical, Inc. She is on the Board of Directors at Telesis Bio, Inc., Cerus Corp., Intuitive Surgical, Inc. and The Tech Interactive. Ms. Nachtsheim was previously employed as a Chairman by Affymetrix, Inc. and a Vice President-Sales & Marketing Group by Intel Corp. She also served on the board at FEI Co., ACT Conferencing, Inc., Southwall Technologies, Inc., Vixel Corp. and Worldwide Marketing, Inc. She received her undergraduate degree from Arizona State University. |
| Gail Gaumer Schulze |
Gail Gaumer Schulze currently works at Cerus Corp., as Independent Director from 2007. Ms. Schulze also formerly worked at Eximias Pharmaceutical Corp., as President, Chief Executive Officer & Director, Aventis Behring, as COO & Deputy Chief Executive Officer from 1997 to 2004, YM Biosciences USA, Inc., as Chief Executive Officer & Director from 2006 to 2007, ZP Opco, Inc., as Chairman in 2012, Baxter Healthcare Corp., as President-Renal Division Europe from 1979 to 1995, YM BioSciences, Inc., as President from 2006 to 2007, and Allegiance Healthcare Corp., as Vice President from 1996 to 1997. Ms. Schulze received her undergraduate degree from the University of California, Santa Cruz and Masters Business Admin degree from Stanford Graduate School of Business. |
| Timothy L. Moore |
Timothy L. Moore is currently serving as the Independent Director at BioLife Solutions, Inc. since 2022 and at Cerus Corp. since 2018. He is also a Member of the International Society for Pharmaceutical Engineering and the Parenteral Drug Association. In 2023, he will assume the role of Chief Technical Officer & Executive Vice President at Allogene Therapeutics, Inc. Previously, Mr. Moore held positions as the Independent Non-Executive Director at Cognate BioServices, Inc., Director at Fusionkite, Senior Vice President-Global Supply Chain at Genentech, Inc. from 2004 to 2010, Vice President-Operations at Aventis Behring from 2000 to 2004, and Vice President-Operations at CSL Behring LLC. He also served as the Executive Vice President-Technical Operations at Kite Pharma, Inc. from 2016 to 2019 and as the President, Chief Operating & Technical Officer at PACT Pharma, Inc. Mr. Moore's education includes a graduate degree from Northwestern University and an undergraduate degree from The University of Tulsa. |
| Eric Hands Claude Bjerkholt |
Eric Hands Claude Bjerkholt was the founder of LifeSpring Home Nutrition (founded in 1999) and Kenady LLC (founded in 1999), where he held the titles of President, Chief Executive & Financial Officer. Currently, Mr. Bjerkholt holds the position of Independent Director at Cerus Corp. (since 2018), Director at Aimmune Therapeutics UK Ltd. (since 2018), Independent Director at Surrozen, Inc. (since 2023), Independent Director at CalciMedica, Inc. (since 2023), and Chief Financial Officer at Mirum Pharmaceuticals, Inc. (since 2023). In the past, Mr. Bjerkholt has held positions such as Independent Director at StemCells, Inc. (2011-2016), Independent Director at Graybug Vision, Inc., Director at Round Table Pizza, Inc., Independent Director at Ambrx, Inc., Director at Corium International, Inc. (2015-2018), Director at Atara Biotherapeutics, Inc., Director at Structure Therapeutics, Inc., Chief Financial Officer & Senior Vice President at IntraBiotics Pharmaceuticals, Inc. (2002-2004), CFO, Secretary & EVP-Corporate Development at Sunesis Pharmaceuticals, Inc. (2012-2017), Chief Financial Officer at Aimmune Therapeutics, Inc. (2017-2020), and Vice President at J.P. Morgan & Co., Inc. (Delaware) (1990-1997). Mr. Bjerkholt's education includes an undergraduate degree from the University of Oslo and an MBA from Harvard Business School. |
| Franklin R. Witney |
Franklin R. Witney is currently the Chairman at Gyros AB, Gyros Protein Technologies AB, Canopy Biosciences LLC, Jumpcode Genomics, Inc., Telesis Bio, Inc., Cerus Corp., Revvity, Inc., Standard BioTools, Inc., Genoptix, Inc., One Lambda, Inc., Revvity BV, Nexcelom Bioscience LLC, RareCyte, Inc., Emulate, Inc., and Leinco Technologies, Inc. He previously held positions as the President, Chief Executive Officer & Director at Dionex Corp. from 2009 to 2011, President, Chief Executive Officer & Director at Affymetrix, Inc. from 2011 to 2016, President & Chief Executive Officer at Panomics LLC from 2002 to 2008, and Operations Manager-Life Science Group at Bio-Rad Laboratories, Inc. from 1983 to 2000. Dr. Witney also served as the Chief Commercial Officer & Executive VP at Affymetrix, Inc. from 2008 to 2009, President & Chief Operating Officer at Packard BioScience Co. from 2000 to 2001, President-Drug Discovery Tools at PerkinElmer Life Sciences, Inc. from 2001 to 2002, and President of Drug Discovery Facility from 2001 to 2002. He has a doctorate degree from Indiana University and an undergraduate degree from the University of Illinois. |
| Hua Shan |
Hua Shan has worked as an Independent Director at Cerus Corp. since 2022 and currently holds the position of Medical Director-Transfusion Medicine Service at Stanford University Medical Center. |
